Similar impact and replacement disease after pneumococcal conjugate vaccine introduction in hospitalised children with invasive pneumococcal disease in Europe and North America
Open Access
- 18 February 2021
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 39 (11), 1551-1555
- https://doi.org/10.1016/j.vaccine.2021.01.070
Abstract
No abstract availableFunding Information
- GlaxoSmithKline
- Sanofi
- Pfizer
- GlaxoSmithKline
This publication has 18 references indexed in Scilit:
- Making sense of differences in pneumococcal serotype replacementThe Lancet Infectious Diseases, 2019
- Long-term impact of 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease among children in FinlandVaccine, 2018
- Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort studyThe Lancet Infectious Diseases, 2018
- Incidence of invasive pneumococcal disease before and during an era of use of three different pneumococcal conjugate vaccines in QuebecVaccine, 2017
- Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the NetherlandsEmerging Infectious Diseases, 2015
- Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillanceThe Lancet Infectious Diseases, 2015
- Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort studyThe Lancet Infectious Diseases, 2011
- Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate VaccineThe Journal of Infectious Diseases, 2010
- Incidence of Pneumococcal Disease Due to Non–Pneumococcal Conjugate Vaccine (PCV7) Serotypes in the United States during the Era of Widespread PCV7 Vaccination, 1998–2004The Journal of Infectious Diseases, 2007
- Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate VaccineThe New England Journal of Medicine, 2003